Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation
Mihály Hajós(Pfizer (United States)), Éva Hajós‐Korcsok(Pfizer (United States)), Charles E. Nolan(Pfizer (United States)), Elena Morozova(Pfizer (United States)), Chester J. Siok(Pfizer (United States)), Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tamás Kiss(Pfizer (United States)), David Riddell(Eli Lilly (United States))
Cited by 12
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302